138 related articles for article (PubMed ID: 12830011)
1. Interleukin 1beta gene polymorphism and hepatitis C virus-related hepatocellular carcinoma.
Yeo AE; Tanaka Y; Furuta T
Hepatology; 2003 Jul; 38(1):267-8; author reply 268-9. PubMed ID: 12830011
[No Abstract] [Full Text] [Related]
2. Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan.
Tanaka Y; Furuta T; Suzuki S; Orito E; Yeo AE; Hirashima N; Sugauchi F; Ueda R; Mizokami M
J Infect Dis; 2003 Jun; 187(11):1822-5. PubMed ID: 12751042
[TBL] [Abstract][Full Text] [Related]
3. Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients.
Leveri M; Gritti C; Rossi L; Zavaglia C; Civardi E; Mondelli MU; De Silvestri A; Silini EM
Cancer Lett; 2004 May; 208(1):75-9. PubMed ID: 15105048
[TBL] [Abstract][Full Text] [Related]
4. StatBite: Hepatitis C virus-related hepatocellular carcinoma incidence among men in Osaka.
J Natl Cancer Inst; 2008 Jul; 100(14):987. PubMed ID: 18612126
[No Abstract] [Full Text] [Related]
5. Hepatitis C virus and hepatocellular carcinoma.
Shimotohno K
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():290. PubMed ID: 7661598
[No Abstract] [Full Text] [Related]
6. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma.
Brechot C
Hepatology; 1997 Mar; 25(3):772-4. PubMed ID: 9049234
[No Abstract] [Full Text] [Related]
7. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma.
Feitelson MA
Cancer Lett; 2006 Jul; 239(1):10-20. PubMed ID: 16154256
[TBL] [Abstract][Full Text] [Related]
8. Cytokine polymorphisms and hepatocellular carcinoma: to B or not to B.
Chung RT
Cancer; 2005 Feb; 103(4):654-6. PubMed ID: 15641028
[No Abstract] [Full Text] [Related]
9. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
[TBL] [Abstract][Full Text] [Related]
10. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
11. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus and hepatocellular carcinoma.
Giacosa A; Hill MJ
Eur J Cancer Prev; 1996 Dec; 5(6):423-4. PubMed ID: 9061272
[No Abstract] [Full Text] [Related]
13. Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile.
Tsunedomi R; Iizuka N; Yamada-Okabe H; Tamesa T; Okada T; Sakamoto K; Takashima M; Hamaguchi T; Miyamoto T; Uchimura S; Hamamoto Y; Yamada M; Oka M
Int J Oncol; 2006 Dec; 29(6):1445-51. PubMed ID: 17088983
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of replicating hepatitis C virus quasispecies in hepatocellular carcinoma tissues using PCR-SSCP method].
Kurosaki M; Enomoto N; Sakamoto N; Sato C
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):796-9. PubMed ID: 7563877
[No Abstract] [Full Text] [Related]
15. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
16. Unusually high incidence of hepatitis B virus integration into the MLL gene in hepatocellular carcinoma.
Minami M; Fujii K; Miyagawa M; Okanoue T
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3549; author reply 3549-50. PubMed ID: 16740782
[No Abstract] [Full Text] [Related]
17. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and natural history of hepatocellular carcinoma.
McGlynn KA; London WT
Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
[TBL] [Abstract][Full Text] [Related]
19. Resampling based on geographic patterns of hepatitis virus infection reveals a common gene signature for early intrahepatic recurrence of hepatocellular carcinoma.
Uchimura S; Iizuka N; Tamesa T; Miyamoto T; Hamamoto Y; Oka M
Anticancer Res; 2007; 27(5A):3323-30. PubMed ID: 17970077
[TBL] [Abstract][Full Text] [Related]
20. Outcome of patients with hepatitis C virus-related single, small hepatocellular carcinoma.
Sako K; Komorizono Y; Oketani M; Hasegawa S; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Yasunari H; Sakurai K; Hiwaki T; Ishibashi K; Arima T
Anticancer Res; 2003; 23(5b):4191-6. PubMed ID: 14666624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
